REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 161 filers reported holding REVANCE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 2.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $950,232 | -65.5% | 82,845 | -23.9% | 0.00% | -66.7% |
| Q2 2023 | $2,756,663 | +473.1% | 108,916 | +341.8% | 0.00% | – |
| Q1 2022 | $481,000 | -48.9% | 24,653 | -57.3% | 0.00% | -100.0% |
| Q4 2021 | $942,000 | -39.1% | 57,735 | +3.9% | 0.00% | -50.0% |
| Q3 2021 | $1,547,000 | +156.6% | 55,544 | +173.2% | 0.00% | +100.0% |
| Q2 2021 | $603,000 | -70.5% | 20,334 | -72.2% | 0.00% | -50.0% |
| Q1 2021 | $2,041,000 | +116.0% | 73,016 | +119.0% | 0.00% | +100.0% |
| Q4 2020 | $945,000 | -32.6% | 33,334 | -40.2% | 0.00% | -50.0% |
| Q3 2020 | $1,402,000 | -2.7% | 55,785 | -5.5% | 0.00% | 0.0% |
| Q2 2020 | $1,441,000 | +396.9% | 59,018 | +221.3% | 0.00% | +100.0% |
| Q1 2019 | $290,000 | – | 18,371 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 4,592,047 | $121,230,000 | 21.92% |
| Rhenman & Partners Asset Management AB | 220,000 | $5,808,000 | 0.83% |
| ArrowMark Colorado Holdings LLC | 2,045,862 | $54,011,000 | 0.67% |
| Vivo Capital, LLC | 77,373 | $2,043,000 | 0.52% |
| Ghost Tree Capital, LLC | 89,295 | $2,357,000 | 0.49% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 124,932 | $3,298,000 | 0.47% |
| Polar Capital LLP | 1,296,371 | $34,220,000 | 0.46% |
| SUFFOLK CAPITAL MANAGEMENT LLC | 70,095 | $1,851,000 | 0.24% |
| EAM Investors, LLC | 33,897 | $895,000 | 0.15% |
| PointState Capital LP | 438,200 | $11,568,000 | 0.13% |